Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Cladribine Venetoclax in Monocytic AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
- Status
- RECRUITING
- Phase
- PHASE2
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
- Status
- WITHDRAWN
- Phase
- PHASE2
Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia
- Status
- RECRUITING
- Phase
- N/A
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
- Status
- RECRUITING
- Phase
- NA
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
- Status
- TERMINATED
- Phase
- PHASE1
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
CIML NK Cells With Venetoclax for AML
- Status
- RECRUITING
- Phase
- PHASE1
Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).
- Status
- RECRUITING
- Phase
- PHASE2